If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: -0.25 (-1.41%)
Spread: 1.00 (5.882%)
Open: 17.75
High: 17.75
Low: 17.50
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Victorian Plumbing profit up; Duke revenue dips

Wed, 22nd Nov 2023 14:15

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Tremor International Ltd - Israel-headquartered company offering an end-to-end technology advertising platform - Says revenue in the third quarter of the year grew 13% to USD80.1 million from USD70.9 million the year prior. Nevertheless, swings to pretax loss to USD4.04 million from a USD3.50 million profit the year before. Operating costs increase 33% to USD69.8 million from USD52.7 million. Looking ahead, it says ongoing uncertainty will limit customer spending through to the rest of 2023. Expects approximately between USD80 million and USD85 million in adjusted earnings before interest, tax, depreciation and amortisation for the full year.

----------

Rockwood Strategic PLC - London-based investor in smaller UK public companies, formerly known as Rockwood Realisation PLC - Says net asset value per share at September 30 was 1,851.62 pence, down from 1,959.56p at March 31. NAV total return in six months to September 30 was negative 5.5%, compared to a decline in the FTSE AIM All Share Index of negative 10.3%. Chair Noel Lamb says: "The first half of our financial year has been a challenging one for UK small company stock market investors, with sustained outflows from the asset class amidst negative sentiment as interest rates continued to rise against a subdued economic backdrop. For those with sensible time horizons, these are typically the conditions for positive future medium-term returns, not least due to the heavily depressed valuations of small company shares relative to history. Private equity and trade buyers are clearly recognising the opportunities created by this environment, with the drumbeat of takeovers within Rockwood's portfolio continuing throughout 2023. We are delighted that during the period, the long-standing share price discount to Net Asset Value was closed, and we were able to grow our shareholder base."

----------

Victorian Plumbing Group PLC - Lancashire, England-based bathroom retailer - Says pretax profit in the year ended September 30 grows 32% GBP15.6 million from GBP11.8 million a year prior as revenue rises 5.8% to GBP285.1 million from GBP269.4 million the year before. Proposes a final dividend of 0.95 pence per share, bringing the total dividend to 1.40p per share, up 73% from 1.10p the year before. Looking ahead, it says it is "confident" in future growth prospects. Chief Executive Officer Mark Radcliffe says: "As a highly cash generative business with a strong balance sheet, we continue to invest in the business - across people, technology and infrastructure. Our new purpose-built 544,000 square feet distribution centre, once operational, will enable further growth in the core bathroom category, as well as unlocking further strategic category expansion. We are confident that Victorian Plumbing's profitable growth strategy will continue to deliver long-term value to all stakeholders."

----------

Duke Royalty Ltd - Guernsey-based provider of royalty finance to companies in UK and Europe - Says total revenue for the half year ended September 30 falls 66% to GBP10.4 million from GBP31.0 million the year before. Recurring cash revenue totalled GBP12.2 million, up 17% from GBP10.4 million in the first half of financial 2023. Pretax profit stoops by 81% to GBP3.8 million from GBP20.4 million a year prior. Maintains its quarterly dividend of 0.70 pence per share. Looking ahead, says it is "well-positioned" for growth. Chair Nigel Birrell comments: "During the interim period, Duke was able to post its twelfth consecutive quarter of increasing recurring cash revenue, which was a fantastic achievement for the company. In line with this strong financial performance, the company also maintained its quarterly dividend of 0.70p per share. Investors can be reassured that the dividend payout remains well covered by operating cashflow, with the attractive yield representing a pillar of Duke's ongoing business model and its overall financial discipline."

----------

Atlantic Lithium Ltd - Sydney-based lithium exploration and development company, with assets in Ghana and Ivory Coast - Says beginning of construction of Ewoyaa lithium project in Ghana will begin in late 2024, with initial production expected in early 2025. CEO Keith Muller says: "Being now within only two years from initial production, the company continues to actively recruit experienced individuals to bolster the expertise of the leadership team ahead of mine build and operation, while also ensuring a successful transition to becoming a lithium producer. We are delighted to welcome three general managers to the team, each bringing significant expertise from across the mining sector. We expect to continue to grow our teams, both in Ghana and in Australia, as we near construction."

----------

OptiBiotix Health PLC - York, England-based life sciences company - Wins grant from the University of Reading for research of its prebiotic and mineral complex, WellBiome. Says the study will assess Well Biome's impact on the gut microbiome. CEO Stephen O'Hara says: "The award of this grant to investigate WellBiome's impact on the gut microbiome throughout its length is another step in OptiBiotix's strategy of developing science based functional ingredients which modify the human microbiome to improve health. Consumer understanding and interest in the microbiome and the role of gut health in general health and wellbeing is growing rapidly, particularly in the US, and this is creating a market opportunity that is large and expanding."

----------

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
28 Sep 2022 13:57

EARNINGS SUMMARY: Skillcast cuts dividend on swing to interim loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
26 Sep 2022 21:46

TRADING UPDATES: Goldplat appoints chair; 3i portfolios make progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
26 Sep 2022 14:18

OptiBiotix launching new product in deal with Shandong Longlive

(Sharecast News) - Life science company OptiBiotix Health has signed an exclusive distribution agreement with Shandong Longlive Biotechnology, it announced on Monday, for the distribution of Longlive's unique xylooligosaccharide (XOS) prebiotic into the human nutrition markets in Europe and Africa.

Read more
20 Sep 2022 20:50

TRADING UPDATES: Gaming Realms, Northcoders revenue up; Boku wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Sep 2022 11:37

OptiBiotix launches range into large Indian chemist chain

(Sharecast News) - OptiBiotix Health announced on Tuesday that its subsidiary OptiBiotix Ltd launched its 'GoFigure' range with Apollo Hospitals & Pharmacies on 18 September.

Read more
14 Sep 2022 14:25

IN BRIEF: OptiBiotix Health subsidiary signs Asia Pacific agreement

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Says its wholly owned subsidiary OptiBiotix Ltd has signed a services agreement with Nutraconnect Pte Ltd for the Asia Pacific region. Notes that Nutraconnect will develop and implement the go-to-market strategy for prebiotics ingredients SlimBiome and LeanBiome. "Nutraconnect is a nutraceutical business growth acceleration service headquartered in Singapore," the company says.

Read more
24 Aug 2022 15:38

OptiBiotix tumbles as it warns of 'materially lower' sales

(Sharecast News) - Life sciences company OptiBiotix Health said in a trading update on Wednesday that, based on initial figures, it expected first-half sales in its new structure to be "materially lower than expected" at around £0.12m.

Read more
24 Aug 2022 10:43

OptiBiotix shares plunge on "very difficult trading" in half-year

(Alliance News) - OptiBiotix Health PLC on Wednesday lamented a strenuous half-year but eyed growing sales and business, seeing itself in a strong position.

Read more
24 Aug 2022 10:32

AIM WINNERS & LOSERS: Gfinity up on Athlos launch; OptiBiotix slides

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
19 Jul 2022 15:57

UK shareholder meetings calendar - next 7 days

Wednesday 20 July 
ADM Energy PLC AGM
Alkemy Capital Investments PLCAGM
DeepVerge PLCAGM
easyJet PLCGM re purchase of 56 Airbus A320neo family aircraft & conversion of 18 A320neo family aircraft
Fidelity China Special Situations PLCAGM
HarbourVest Global Private Equity LtdAGM
HICL Infrastructure PLCAGM
Novacyt SAAGM 
Plaza Centers NVAGM
Premier Foods PLCAGM
Royal Mail PLCAGM
Triad Group PLCAGM
Wynnstay Properties PLCAGM & GM re share buyback
Thursday 21 July  
Big Yellow Group PLCAGM
Evgen Pharma PLCAGM
Experian PLCAGM
Halma PLCAGM
Intermediate Capital Group PLCAGM
Johnson Matthey PLCAGM
Octopus AIM VCT PLCAGM
Pennon Group PLCAGM
Pires Investments PLCGM re offer from Tern PLC
QinetiQ Group PLCAGM
SSE PLCAGM
Tern PLCGM re offer for Pires Investments PLC
Vp PLCAGM
Workspace Group PLCAGM
Zephyr Energy PLCAGM
Friday 22 July  
Chesterfield Resources PLCAGM
Homeserve PLCGM re offer by affiliates of Brookfield Infrastructure Partners LP
JD Sports Fashion PLCAGM
Landore Resources LtdAGM
President Energy PLCAGM
United Utilities Group PLCAGM
WANdisco PLCAGM
Monday 25 July 
BP Marsh & Partners PLCAGM
Keras Resources PLCAGM
Keras Resources PLCGM re share consolidation
Tuesday 26 July 
AO World PLCAGM
Bytes Technology Group PLCAGM
Dekel Agri-Vision PLCAGM
Firering Strategic Minerals PLCAGM
Mitie Group PLCAGM
Momentum Multi-Asset Value Trust PLCAGM
nanosynth group PLCAGM
NewRiver REIT PLCAGM
Ninety One PLC & LtdAGM
OnTheMarket PLCAGM
OptiBiotix Health PLCAGM
Telecom Plus PLCAGM
Vodafone Group PLCAGM
Xeros Technology Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Jun 2022 12:19

IN BRIEF: OptiBiotix Health annual profit up; confident in prospects

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Reports higher profit and revenue in 2021 as probiotic business sells more. Pretax profit rises to GBP6.2 million from GBP5.7 million in 2020. Revenue from contracts with customers grows 45% to GBP2.2 million from GBP1.5 million.

Read more
20 Jun 2022 11:03

OptiBiotix welcomes Steen Anderson as new CEO of ProBiotix spin-off

(Alliance News) - OptiBiotix Health PLC on Monday noted the change in leadership at its recently AQSE-listed spin-off company ProBiotix Health PLC.

Read more
31 Mar 2022 15:15

IN BRIEF: OptiBiotix spin-off ProBiotix Health starts trading on Aquis

ProBiotix Health PLC - developing probiotics to tackle cardiovascular disease and other lifestyle conditions - Starts trading on Aquis Stock Exchange on Thursday after raising GBP2.5 million in initial public offering. ProBiotix sells 11.9 million shares at 21 pence each, giving the company a GBP25.5 million market capitalisation upon admission. No trades of the stock are reported by AQSE on Thursday. ProBiotix made GBP1.1 million in sales in 2021.

Read more
17 Mar 2022 16:37

OptiBiotix set to list ProBiotix subsidiary on AQSE

(Sharecast News) - OptiBiotix Health announced its intention to list its subsidiary ProBiotix Health on the AQSE Growth Market of the Aquis Stock Exchange on Thursday.

Read more
28 Feb 2022 19:41

TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.